HALOZYME THERAPEUTICS, INC. (HALO)
Halozyme Therapeutics, Inc. is a biopharmaceutical company headquartered in San Diego, California, with operations spanning the United States, Switzerland, Ireland, Belgium, Japan, and other international markets. At its core is the proprietary ENHANZE drug delivery platform, which utilizes a patented recombinant human hyaluronidase enzyme (rHuPH20). This innovative technology significantly enhances the subcutaneous (under-the-skin) administration of a diverse range of injectable medicines. This includes complex biologics such as monoclonal antibodies, various other therapeutic molecules, smaller drug compounds, and even fluids. The company's leading product, Hylenex recombinant, is an rHuPH20 formulation specifically designed to facilitate subcutaneous fluid delivery for hydration. It also plays a crucial role in improving the dispersion and absorption of other injected drugs during subcutaneous urography, and aids in the resorption of radiopaque agents. Halozyme also offers several key therapeutics leveraging its platform, including Perjeta, RITUXAN HYCELA, and MabThera SC, which are used to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL). RITUXAN SC is another offering for CLL patients, while HYQVIA addresses various immunodeficiency disorders. Their development pipeline boasts numerous investigational drugs, such as Tecentriq for non-small cell lung cancer, OCREVUS for multiple sclerosis, and DARZALEX, which targets amyloidosis, smoldering myeloma, and multiple myeloma. Other pipeline candidates include nivolumab for solid tumors, ARGX-113 (a human neonatal Fc receptor), ARGX-117 for autoimmune diseases, and BMS-986179, an anti-CD-73 antibody. Halozyme maintains extensive collaborations with prominent pharmaceutical companies like F. Hoffmann-La Roche, Pfizer Inc., Janssen Biotech, Inc., AbbVie, Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Alexion Pharma Holding, ARGENX BVBA, and Horizon Therapeutics plc. They also partner with research institutions such as the National Institute of Allergy and Infectious Diseases, the Centre for the AIDS Programme of Research in South Africa, and ViiV Healthcare Limited, particularly focusing on both small and large molecule targets for the treatment and prevention of HIV. The company was established in 1998.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Halozyme Therapeutics, Inc.
NASDAQ:HALOHealthcare · Biotechnology
-0.21%$130.91
AH$129.48-1.09%vs close
Mkt Cap$14.86B
Float110.43M
O/S113.5M
Vol
$ Vol
RVOL
Inst Own-
SI12.4%
Earnings
Dilution
Financials Summary
Revenue$1.4B
Net Income$316.89M
Total Assets$2.53B
Free Cash Flow$644.59M
Debt & Equity
Debt 98%
Equity 2%
Total Debt$2.14B
Total Equity$48.81M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in HALO's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$2.53B
Liabilities$2.48B
Accounts Receivable$441.27M
Accounts Payable$20.9M
Inventory$176.47M
PP&E (Net)$82.14M
Goodwill$580.36M
Intangible Assets$981.47M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 |
| Revenue | $1.4B | $1.02B | $829.25M | $660.12M | $443.31M | $267.59M | $195.99M | $151.86M | $316.61M | $146.69M | $135.06M | $75.33M | $54.8M | $42.33M | $56.09M | $13.62M | $13.67M | $8.76M | $3.8M | $982K | $127K | $0 | $26K | $88K | $25K |
| YoY Growth | 37.6% | 22.4% | 25.6% | 48.9% | 65.7% | 36.5% | 29.1% | -52.0% | 115.8% | 8.6% | 79.3% | 37.5% | 29.5% | -24.5% | 311.7% | -0.3% | 56.0% | 130.7% | 287.0% | 671.8% | - | - | -70.7% | 255.6% | - |
| Cost of Revenue | $228.77M | $159.42M | $192.36M | $139.3M | $81.41M | $43.37M | $45.55M | $10.14M | $31.15M | $33.21M | $29.25M | $22.73M | $6.25M | $1.09M | $258K | $985K | $312K | $332K | $240K | $437K | $52K | $0 | $27K | $50K | $16K |
| Gross Profit | $1.17B | $855.91M | $636.89M | $520.81M | $361.9M | $224.23M | $150.45M | $141.73M | $285.46M | $113.48M | $105.81M | $52.6M | $48.55M | $41.23M | $55.83M | $12.64M | $13.36M | $8.43M | $3.56M | $545K | $75K | $0 | -$1K | $38K | $9K |
| Gross Margin | 83.6% | 84.3% | 76.8% | 78.9% | 81.6% | 83.8% | 76.8% | 93.3% | 90.2% | 77.4% | 78.3% | 69.8% | 88.6% | 97.4% | 99.5% | 92.8% | 97.7% | 96.2% | 93.7% | 55.5% | 59.1% | - | -5.0% | 43.4% | 35.8% |
| Research and Development | $81.49M | $79.05M | $76.36M | $66.61M | $35.67M | $34.24M | $140.8M | $150.25M | $150.64M | $150.84M | $93.24M | $79.7M | $96.64M | $70.04M | $57.56M | $51.77M | $56.61M | $44.23M | $20.55M | $9.21M | $10.22M | $6.52M | $0 | $0 | $0 |
| Selling, General, and Administrative | $207.09M | $154.34M | $149.18M | $143.53M | $50.32M | $45.74M | $77.25M | $60.8M | $53.82M | $45.85M | $40.03M | $35.94M | $32.35M | $24.81M | $18.1M | $15.12M | $15.2M | $14.63M | $11.16M | $6.91M | $3.42M | $2.57M | $78K | $350 | $49K |
| Other | $76.66M | $71.05M | $73.77M | $43.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $14K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $77K | $0 |
| Total Operating Expenses | $365.24M | $304.43M | $299.32M | $253.28M | $86M | $79.97M | $218.06M | $211.06M | $204.46M | $196.69M | $133.26M | $115.64M | $128.99M | $94.86M | $75.67M | $66.9M | $71.82M | $58.87M | $31.71M | $16.13M | $13.64M | $9.09M | $78K | $77K | $49K |
| Operating Income (EBIT) | $802.59M | $551.48M | $337.57M | $267.53M | $275.9M | $144.25M | -$67.61M | -$69.33M | $81M | -$83.21M | -$27.45M | -$63.04M | -$80.43M | -$53.63M | -$19.84M | -$54.26M | -$58.46M | -$50.43M | -$28.15M | -$15.58M | -$13.56M | -$9.09M | -$79K | -$39K | -$40K |
| Operating Margin | 57.5% | 54.3% | 40.7% | 40.5% | 62.2% | 53.9% | -34.5% | -45.7% | 25.6% | -56.7% | -20.3% | -83.7% | -146.8% | -126.7% | -35.4% | -398.2% | -427.6% | -575.5% | -740.9% | -1587.3% | -10660.7% | - | -307.7% | -44.9% | -160.9% |
| Interest Expense | $18.13M | $18.09M | $18.76M | $16.95M | $7.53M | $20.38M | $11.63M | $18.04M | $21.98M | $19.98M | $5.2M | $5.58M | $3.27M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $59K | $0 | $49K | $98K | $1.72M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$335.72M | $5.66M | $10.76M | -$18.61M | -$27.38M | -$14.95M | -$4.64M | -$10.46M | -$19.39M | -$18.65M | -$4.78M | -$5.34M | -$3.04M | $73K | $69K | $1.02M | $98K | $1.72M | $4.25M | $831K | $286K | -$4K | $0 | -$25K | $54 |
| Income Before Tax (EBT) | $466.88M | $557.13M | $348.33M | $248.92M | $248.52M | $129.3M | -$72.25M | -$79.79M | $61.61M | -$101.86M | -$32.23M | -$68.38M | -$83.48M | -$53.55M | -$19.77B | -$53.24M | -$58.36M | -$48.72M | $0 | $0 | -$13.28M | -$9.09M | $0 | -$64K | -$40K |
| Income Tax Expense | $149.99M | $113.04M | $66.73M | $46.79M | -$154.19M | $217K | -$11K | $537K | -$1.36M | $1.16M | $0 | $0 | $2.05M | -$1.14M | -$1.16M | $0 | $0 | -$63K | -$4.25M | -$831K | $0 | $4K | $79K | $800 | $0 |
| Net Income | $316.89M | $444.09M | $281.59M | $202.13M | $402.71M | $129.09M | -$72.24M | -$80.33M | $62.97M | -$103.02M | -$32.23M | -$68.38M | -$83.48M | -$53.55M | -$19.77M | -$53.24M | -$58.36M | -$48.65M | -$23.9M | -$14.75M | -$13.28M | -$9.09M | -$79K | -$65K | -$40K |
| Net Income Margin | 22.7% | 43.7% | 34.0% | 30.6% | 90.8% | 48.2% | -36.9% | -52.9% | 19.9% | -70.2% | -23.9% | -90.8% | -152.3% | -126.5% | -35.2% | -390.8% | -426.9% | -555.2% | -628.9% | -1502.6% | -10435.9% | - | -307.7% | -74.4% | -160.6% |
| Supplementary Data | |||||||||||||||||||||||||
| EPS | 2.64 | 3.50 | 2.13 | 1.48 | 2.86 | 0.95 | -0.50 | -0.56 | 0.46 | -0.81 | -0.25 | -0.56 | -0.74 | -0.48 | -0.19 | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 | -0.26 | -0.26 | -0.01 | -0.01 | -0.03 |
| Diluted EPS | 2.56 | 3.43 | 2.10 | 1.44 | 2.74 | 0.91 | -0.50 | -0.56 | 0.45 | -0.81 | -0.25 | -0.56 | -0.74 | -0.48 | -0.19 | -0.56 | -0.67 | -0.61 | -0.32 | -0.24 | -0.26 | -0.26 | -0.01 | -0.01 | -0.03 |
| Weighted Average OS | 119.84M | 126.83M | 131.93M | 136.84M | 140.65M | 136.21M | 144.33M | 143.45M | 136.42M | 127.19M | 126.70M | 122.69M | 112.81M | 111.08M | 102.57M | 94.36M | 86.70M | 79.84M | 74.32M | 62.61M | 50.32M | 35.41M | 6.83M | 4.60M | 1.20M |
| EBITDA | $573.05M | $656.54M | $451.95M | $315.51M | $259.04M | $152.96M | -$56.56M | -$69.33M | $83.16M | -$79.47M | -$25.35M | -$61.03M | -$78.98M | -$52.47M | -$18.67M | -$52.75M | -$56.92M | -$49.39M | -$28.15M | -$14.51M | -$13.36M | -$8.96M | -$79K | -$14K | -$40K |
| EBITDA Margin | 41.0% | 64.7% | 54.5% | 47.8% | 58.4% | 57.2% | -28.9% | -45.7% | 26.3% | -54.2% | -18.8% | -81.0% | -144.1% | -124.0% | -33.3% | -387.2% | -416.3% | -563.5% | -740.9% | -1477.8% | -10498.5% | - | -307.7% | -16.3% | -160.9% |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 |
| Assets | |||||||||||||||||||||||||
| Current Assets | |||||||||||||||||||||||||
| Cash and Cash Equivalents | $133.82M | $115.85M | $118.37M | $234.19M | $118.72M | $147.7M | $120.18M | $57.94M | $168.74M | $66.76M | $43.29M | $61.39M | $27.36M | $99.9M | $52.83M | $83.26M | $67.46M | $63.72M | $97.68M | $44.19M | $19.13M | $16.01M | $48K | $97K | $26K |
| Short-Term Investments | $9M | $480.22M | $217.63M | $128.6M | $622.2M | $220.31M | $301.08M | $296.59M | $300.47M | $138.22M | $65.05M | $74.23M | $44.15M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $142.82M | $596.07M | $336M | $362.79M | $740.92M | $368.01M | $421.26M | $354.53M | $469.21M | $204.98M | $108.34M | $135.62M | $71.5M | $99.9M | $52.83M | $83.26M | $67.46M | $63.72M | $97.68M | $44.19M | $19.13M | $16.01M | $48K | $97K | $26K |
| Accounts Receivable | $441.27M | $308.45M | $234.21M | $231.07M | $90.97M | $97.73M | $59.44M | $30M | $22.13M | $15.68M | $32.41M | $9.15M | $9.1M | $15.7M | $2.26M | $2.33M | $4.24M | $7.26M | $780K | $0 | $414K | $0 | $0 | $0 | $0 |
| Inventory | $176.47M | $141.86M | $127.6M | $100.12M | $53.91M | $60.75M | $29.36M | $22.63M | $5.15M | $14.62M | $9.49M | $6.41M | $6.17M | $2.67M | $567K | $193K | $1.16M | $441K | $703K | $442K | $279K | $52K | $0 | $0 | $0 |
| Other Current Assets | $64.64M | $38.95M | $48.61M | $45.02M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$456K | $0 | $0 |
| Total Current Assets | $825.21M | $1.09B | $746.42M | $739.01M | $926.29M | $554.76M | $543.44M | $427.85M | $510.37M | $256.53M | $171.77M | $161.32M | $95.2M | $131.03M | $63.99M | $89.5M | $74.44M | $74.01M | $101.18M | $45.59M | $20.11M | $16.15M | $48K | $97K | $26K |
| Long-Term Assets | |||||||||||||||||||||||||
| Property, Plant & Equipment Net | $82.14M | $75.03M | $74.94M | $75.57M | $8.79M | $10.59M | $10.86M | $7.46M | $3.52M | $4.26M | $3.94M | $2.95M | $3.42M | $3.7M | $1.77M | $1.85M | $2.71M | $2.55M | $2.28M | $498K | $381K | $236K | $0 | $0 | $0 |
| Goodwill | $580.36M | $416.82M | $416.82M | $409.05M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $981.47M | $401.83M | $472.88M | $546.65M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $500K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $3.85M | $4.39M | $44.43M | $155.43M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $56.15M | $80.6M | $17.82M | $26.8M | $13.41M | $14.57M | $11.58M | $4.93M | $6.05M | $719K | $6.07M | $1.71M | $3.18M | $400K | $0 | $0 | $0 | $0 | $0 | $0 | $23K | $23K | $0 | $0 | $0 |
| Total Long-Term Assets | $1.7B | $978.14M | $986.85M | $1.1B | $178.14M | $25.16M | $22.44M | $12.4M | $9.57M | $4.98M | $10.02M | $4.66M | $6.6M | $3.7M | $1.77M | $1.85M | $2.71M | $2.55M | $2.28M | $498K | $404K | $258K | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.53B | $2.06B | $1.73B | $1.84B | $1.1B | $579.92M | $565.87M | $440.25M | $519.95M | $261.51M | $181.79M | $165.98M | $101.79M | $134.73M | $65.76M | $91.35M | $77.15M | $76.56M | $103.46M | $46.09M | $20.51M | $16.4M | $48K | $97K | $26K |
| Liabilities | |||||||||||||||||||||||||
| Current Liabilities | |||||||||||||||||||||||||
| Accounts Payable | $20.9M | $10.25M | $11.82M | $17.69M | $1.54M | $1.93M | $6.43M | $4.08M | $7.95M | $3.58M | $4.5M | $3M | $3.13M | $2.27M | $7.56M | $3.82M | $2.82M | $6.67M | $3.06M | $2.02M | $1.38M | $1.49M | $33K | $0 | $0 |
| Short-Term Debt | $0 | $0 | $0 | $13.33M | $89.42M | $397.23M | $19.54M | $91.51M | $77.21M | $17.39M | $21.86M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $963K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $3.25M | $1.75M | $1.75M | $4.01M | $4.25M | $6.57M | $4.79M | $9.3M | $7.37M | $7.4M | $8.89M | $4.13M | $2.92M | $5.49M | $3.55M | $3.31M | $1.22M | $254K | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $156.19M | $0 | $0 | -$3.25M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $10K | $3K |
| Total Current Liabilities | $177.09M | $139.1M | $112.49M | $130.79M | $117.15M | $421.38M | $85.64M | $149.36M | $131.33M | $54.59M | $62.46M | $24.33M | $25.45M | $18.95M | $17.3M | $15.34M | $14.4M | $14.22M | $8.86M | $4.25M | $2.3M | $1.58M | $37K | $10K | $3K |
| Long-Term Liabilities | |||||||||||||||||||||||||
| Long-Term Debt | $2.14B | $1.51B | $1.5B | $1.49B | $787.25M | $0 | $383.05M | $34.87M | $125.14M | $199.23M | $27.97M | $49.86M | $49.77M | $29.66M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $2.25M | $2.53M | $4.03M | $1.25M | $5.01M | $54.3M | $39.83M | $43.92M | $47.27M | $45.75M | $34.95M | $37.56M | $55.18M | $54.99M | $45.89M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $42.92M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $795K | -$1.45M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $113.86M | $54.76M | $37.72M | $45.91M | $544K | $3.47M | $4.18M | $2.12M | $814K | $358K | $4.44M | $3.17M | $1.36M | $862K | $802K | $474K | $860K | $1.07M | $36.83M | $18.76M | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $2.3B | $1.56B | $1.54B | $1.54B | $790.33M | $7.49M | $388.47M | $42M | $180.25M | $239.41M | $76.33M | $100.29M | $96.33M | $66.93M | $37.56M | $55.65M | $55.85M | $46.96M | $36.83M | $18.76M | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.48B | $1.7B | $1.65B | $1.67B | $907.48M | $428.88M | $474.11M | $191.36M | $311.58M | $294M | $138.79M | $124.63M | $121.78M | $85.87M | $54.86M | $70.99M | $70.25M | $61.18M | $45.69M | $23.01M | $2.3M | $1.58M | $37K | $10K | $3K |
| Stockholders' Equity | |||||||||||||||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $118K | $123K | $127K | $135K | $138K | $135K | $137K | $145K | $143K | $130K | $128K | $126K | $115K | $113K | $104K | $101K | $92K | $82K | $78K | $69K | $60K | $49K | $8K | $2K | $1K |
| Retained Earnings | $54.79M | $359.87M | $90.55M | $143.22M | -$58.91M | -$474.59M | -$603.68M | -$531.44M | -$522.37M | -$585.34M | -$482.66M | -$450.43M | -$382.05M | -$298.57M | -$245.02M | -$225.25M | -$172.01M | -$113.65M | -$65M | -$41.1M | -$26.35M | -$13.07M | -$184K | -$105K | -$40K |
| Comprehensive Income & Other | -$18.09M | $3.83M | -$9.28M | -$922K | -$620K | $22K | $240K | -$277K | -$450K | -$6K | -$99K | -$41K | $17K | -$6.68M | -$5.75M | -$4.68M | -$3.45M | -$2.04M | -$1.03M | -$705K | -$532K | -$332K | $0 | $0 | $0 |
| Other Stockholders' Equity | -$6.09M | $3.83M | -$6.87M | $26.45M | $255.73M | $625.5M | $695.31M | $780.18M | $730.59M | $552.73M | $525.53M | $491.65M | $361.95M | $347.31M | $255.82M | $245.5M | $178.82M | $128.95M | $122.69M | $64.11M | $44.49M | $27.85M | $186K | $190K | $61K |
| Total Equity | $48.81M | $363.82M | $83.81M | $169.8M | $196.95M | $151.05M | $91.77M | $248.89M | $208.37M | -$32.48M | $43M | $41.35M | -$19.99M | $48.85M | $10.9M | $20.35M | $6.9M | $15.38M | $57.77M | $23.08M | $18.21M | $14.82M | $10K | $87K | $23K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.53B | $2.06B | $1.73B | $1.84B | $1.1B | $579.92M | $565.87M | $440.25M | $519.95M | $261.51M | $181.79M | $165.98M | $101.79M | $134.73M | $65.76M | $91.35M | $77.15M | $76.56M | $103.46M | $46.09M | $20.51M | $16.4M | $48K | $97K | $26K |
| Supplementary Data | |||||||||||||||||||||||||
| Total Debt | $2.14B | $1.51B | $1.5B | $1.51B | $876.67M | $397.23M | $402.59M | $126.38M | $202.35M | $216.62M | $49.83M | $49.86M | $49.77M | $31.11M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Debt | $2.01B | $1.39B | $1.38B | $1.27B | $757.96M | $249.53M | $282.41M | $68.44M | $33.61M | $149.86M | $6.54M | -$11.53M | $22.41M | -$68.79M | -$52.83M | -$83.26M | -$67.46M | -$63.72M | -$97.68M | -$44.19M | -$19.13M | -$16.01M | -$48K | -$97K | -$26K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 | 2005-12-31 | 2004-12-31 | 2003-12-31 | 2002-12-31 | 2001-12-31 |
| Operating Activities | |||||||||||||||||||||||||
| Net Income | $316.89M | $444.09M | $281.59M | $202.13M | $402.71M | $129.09M | -$72.24M | -$80.33M | $62.97M | -$103.02M | -$32.23M | -$68.38M | -$83.48M | -$53.55M | -$19.77M | -$53.24M | -$58.36M | -$48.65M | -$23.9M | -$14.75M | -$13.28M | -$9.09M | -$79K | -$65K | -$40K |
| Depreciation & Amortization | $88.05M | $81.31M | $84.86M | $49.64M | $3M | $3.28M | $4.07M | $2.39M | $2.16M | $2.41M | $1.68M | $1.76M | $1.23M | $1.08M | $1.1M | $1.51M | $1.44M | $1.05M | $576K | $244K | $206K | $123K | $0 | $0 | $0 |
| Deferred Income Tax | $634K | $0 | $34.51M | $0 | $0 | $0 | $0 | -$3.08M | -$257K | $560K | $887K | $1.69M | $1.12M | $7K | $0 | $0 | $0 | -$3.69M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $51.56M | $43.38M | $36.62M | $24.4M | $20.82M | $17.2M | $34.78M | $35.7M | $30.67M | $25.59M | $20.84M | $15.27M | $9.54M | $8.35M | $5.57M | $4.87M | $4.53M | $3.7M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | |||||||||||||||||||||||||
| Accounts Receivable | -$128.06M | -$74.25M | -$3.34M | -$83.94M | $6.75M | -$38.29M | -$29.44M | $11.61M | -$6.45M | $16.73M | -$23.26M | -$52K | $6.61M | -$13.44M | $66K | $1.92M | $3.02M | -$6.48M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $2.55M | -$67.38M | -$26.88M | -$17.48M | $7.37M | -$31.39M | -$6.73M | -$17.48M | $9.48M | -$5.13M | -$3.08M | -$236K | -$3.5M | -$2.1M | -$374K | $966K | -$718K | $262K | -$261K | -$164K | -$227K | -$52K | $0 | $0 | $0 |
| Accounts Payable | $0 | $0 | -$12.55M | $0 | $0 | $0 | $0 | -$278.49M | $15.63M | -$244K | $13.87M | -$816K | $7.89B | -$3.26B | $711.78M | $3.44M | -$2M | $4.79M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | -$26.75M | $5.36M | $4.1M | -$9.06M | -$11.55M | $2.52M | -$19.01M | $278.49M | $2.04M | $5.63M | -$17.02M | $1.21M | -$7.87B | $3.26B | -$732.71M | -$4.85M | $11.94M | $9.97M | $20.85M | $20.46M | $115K | $1.2M | $27K | $7K | $3K |
| Total Working Capital Change | -$152.26M | -$136.27M | -$38.67M | -$110.49M | $2.57M | -$67.16M | -$55.18M | -$5.87M | $20.69M | $16.98M | -$29.5M | $106K | $22.1M | -$20.22M | -$21.24M | $1.47M | $12.24M | $8.53M | $20.59M | $20.3M | -$112K | $1.15M | $27K | $7K | $3K |
| Other Non-Cash Items | $346.68M | $46.55M | -$10.33M | $74.43M | -$129.66M | -$26.96M | $3.15M | $1.7M | $17.82M | $7.11M | $1.24M | $2.02M | $156K | $9K | -$2K | $14K | $3K | $3.7M | $2.58M | $1.29M | $185K | $98K | $2K | $2K | $2K |
| Net Cash from Operating | $651.56M | $479.06M | $388.57M | $240.11M | $299.44M | $55.45M | -$85.42M | -$49.5M | $134.05M | -$50.38M | -$37.08M | -$47.52M | -$49.34M | -$64.33M | -$34.35M | -$45.39M | -$40.15M | -$35.37M | -$148K | $7.08M | -$13M | -$7.72M | -$50K | -$56K | -$34K |
| Investing Activities | |||||||||||||||||||||||||
| Capital Expenditures | -$6.97M | -$10.7M | -$15.29M | -$4.81M | -$1.46M | -$2.5M | -$4.04M | -$4.66M | -$1.35M | -$3.14M | -$2.36M | -$1.37M | -$2.3M | -$1.41M | -$829K | -$647K | -$1.46M | -$1.16M | -$2.37M | -$365K | -$351K | -$228K | $0 | $0 | $0 |
| Acquisitions | -$725.97M | $0 | $0 | -$999.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$247.35M | $0 | -$292.91M | $0 | $0 | $0 | $0 | -$311.11M | -$398.19M | -$155.41M | -$71.48M | -$88.88M | -$48.95M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $722.25M | $0 | $211.3M | $0 | $0 | $0 | $0 | $318.27M | $235.81M | $81.78M | $79.73M | $57.3M | $3.38M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$287.77M | -$252.03M | $0 | $516.92M | -$404.83M | $80.86M | -$1.51M | $7.16M | -$162.38M | -$73.63M | $8.25M | -$31.58M | -$45.57M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$545.81M | -$262.72M | -$96.91M | -$487M | -$406.29M | $78.35M | -$5.55M | $2.49M | -$163.73M | -$76.77M | $5.89M | -$32.95M | -$47.87M | -$1.41M | -$829K | -$647K | -$1.46M | -$1.16M | -$2.37M | -$365K | -$351K | -$228K | $0 | $0 | $0 |
| Financing Activities | |||||||||||||||||||||||||
| Debt Repaid | -$451.13M | - | $13.48M | -$624.55M | -$415.81M | $19.56M | -$339.27M | $77.52M | $15.99M | -$148.76M | - | - | -$19.98M | -$29.66M | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Issuance | $21.83M | $0 | $0 | $0 | $0 | $0 | $0 | $13.72M | $134.87M | $1.86M | $13.1M | $107.71M | $5.08B | $81.48M | $0 | $59.97M | $38.17M | $2.57M | $56M | $18.34M | $16.47M | $15.58M | $0 | $127K | $61K |
| Common Stock Repurchases | -$342.37M | -$250M | -$402.38M | -$200M | -$350.06M | -$150.12M | -$200M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$215.76M | $31.14M | $7.88M | -$62.17M | $12.11M | $63.39M | $13.95M | $13.72M | $12.78M | $1.86M | $13.1M | $6.79M | $25.04B | $0 | $4.75M | $1.86M | $7.18M | $0 | $0 | $0 | $0 | $7.87M | $0 | $0 | $0 |
| Net Cash from Financing | -$85.17M | -$218.86M | -$407.99M | $362.37M | $77.86M | -$106.28M | $153.22M | -$63.8M | $131.66M | $150.62M | $13.1M | $114.5M | $25.06M | $112.82M | $4.75M | $61.82M | $45.36M | $2.57M | $56M | $18.34M | $16.47M | $23.45M | $0 | $127K | $61K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $20.57M | -$2.52M | -$116.33M | $115.48M | -$28.98M | $27.52M | $62.24M | -$110.8M | $101.98M | $23.47M | -$18.1M | $34.03M | -$72.14M | $47.08M | -$30.43M | $15.79M | $3.75M | -$33.96M | $53.49M | $25.06M | $3.12M | $15.5M | -$50K | $71K | $26K |
| Supplementary Data | |||||||||||||||||||||||||
| Operating Cash Flow | $651.56M | $479.06M | $388.57M | $240.11M | $299.44M | $55.45M | -$85.42M | -$49.5M | $134.05M | -$50.38M | -$37.08M | -$47.52M | -$49.34M | -$64.33M | -$34.35M | -$45.39M | -$40.15M | -$35.37M | -$148K | $7.08M | -$13M | -$7.72M | -$50K | -$56K | -$34K |
| Capital Expenditure | -$6.97M | -$10.7M | -$15.29M | -$4.81M | -$1.46M | -$2.5M | -$4.04M | -$4.66M | -$1.35M | -$3.14M | -$2.36M | -$1.37M | -$2.3M | -$1.41M | -$829K | -$647K | -$1.46M | -$1.16M | -$2.37M | -$365K | -$351K | -$228K | $0 | $0 | $0 |
| Free Cash Flow | $644.59M | $468.37M | $373.28M | $235.3M | $297.98M | $52.95M | -$89.46M | -$54.16M | $132.7M | -$53.52M | -$39.44M | -$48.89M | -$51.64M | -$65.74M | -$35.18M | -$46.03M | -$41.61M | -$36.53M | -$2.51M | $6.71M | -$13.35M | -$7.95M | -$50K | -$56K | -$34K |
| Cash at Beginning | $115.85M | $118.37M | $234.69M | $119.22M | $148.2M | $120.68M | $58.44M | $169.24M | $67.26M | $43.29M | $61.39M | $27.36M | $99.5M | $52.83M | $83.26M | $67.46M | $63.72M | $97.68M | $44.19M | $19.13M | $16.01M | $504K | $97K | $26K | $0 |
| Cash at End | $136.42M | $115.85M | $118.37M | $234.69M | $119.22M | $148.2M | $120.68M | $58.44M | $169.24M | $66.76M | $43.29M | $61.39M | $27.36M | $99.9M | $52.83M | $83.26M | $67.46M | $63.72M | $97.68M | $44.19M | $19.13M | $16.01M | $48K | $97K | $26K |